Insider Transactions in Q4 2021 at Change Healthcare Inc. (CHNG)
Insider Transaction List (Q4 2021)
Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
---|---|---|---|---|---|
Dec 29
2021
|
Thomas Mcenery EVP & Chief Marketing Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
57,657
+24.2%
|
$634,227
$11.6 P/Share
|
Dec 28
2021
|
August Calhoun Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
18,937
-10.06%
|
$397,677
$21.44 P/Share
|
Dec 28
2021
|
August Calhoun Officer |
BUY
Grant, award, or other acquisition
|
Direct |
37,451
+16.59%
|
-
|
Dec 28
2021
|
Fredrik J Eliasson EVP & CFO |
SELL
Payment of exercise price or tax liability
|
Direct |
36,274
-7.39%
|
$761,754
$21.44 P/Share
|
Dec 28
2021
|
Fredrik J Eliasson EVP & CFO |
BUY
Grant, award, or other acquisition
|
Direct |
92,180
+15.81%
|
-
|
Dec 28
2021
|
Thomas Laur Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
16,610
-8.83%
|
$348,810
$21.44 P/Share
|
Dec 28
2021
|
Thomas Laur Officer |
BUY
Grant, award, or other acquisition
|
Direct |
37,451
+16.61%
|
-
|
Dec 28
2021
|
Loretta A. Cecil EVP, General Counsel |
SELL
Payment of exercise price or tax liability
|
Direct |
13,865
-9.02%
|
$291,165
$21.44 P/Share
|
Dec 28
2021
|
Loretta A. Cecil EVP, General Counsel |
BUY
Grant, award, or other acquisition
|
Direct |
30,741
+16.67%
|
-
|
Dec 28
2021
|
Thomas Mcenery EVP & Chief Marketing Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
15,074
-10.92%
|
$316,554
$21.44 P/Share
|
Dec 28
2021
|
Thomas Mcenery EVP & Chief Marketing Officer |
BUY
Grant, award, or other acquisition
|
Direct |
30,741
+18.21%
|
-
|
Dec 28
2021
|
Linda Whitley Taylor EVP & Chief People Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
11,962
-8.58%
|
$251,202
$21.44 P/Share
|
Dec 28
2021
|
Linda Whitley Taylor EVP & Chief People Officer |
BUY
Grant, award, or other acquisition
|
Direct |
30,395
+17.9%
|
-
|
Dec 28
2021
|
Roderick H. O'Reilly Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
19,299
-9.86%
|
$405,279
$21.44 P/Share
|
Dec 28
2021
|
Roderick H. O'Reilly Officer |
BUY
Grant, award, or other acquisition
|
Direct |
38,750
+16.52%
|
-
|
Dec 28
2021
|
Neil E. De Crescenzo President & CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
73,976
-6.78%
|
$1,553,496
$21.44 P/Share
|
Dec 28
2021
|
Neil E. De Crescenzo President & CEO |
BUY
Grant, award, or other acquisition
|
Direct |
187,990
+14.7%
|
-
|
Nov 19
2021
|
Paul Rareshide SVP, Corporate Controller |
SELL
Open market or private sale
|
Direct |
4,579
-13.49%
|
$91,580
$20.6 P/Share
|
Nov 11
2021
|
Steven B. Martin EVP, Enterprise Technology |
SELL
Open market or private sale
|
Direct |
8,857
-3.27%
|
$185,997
$21.35 P/Share
|